8 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #Tuberculosis #ActiveTB ... #medications #pharmacology ... #Treatment
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... or been newly diagnosed ... , and sexually active ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis
Algorithm for the management of acute bacterial rhinosinusitis.
IDSA Clinical Practice ... - Overall Treatment ... www.thennt.com/nnt/antibiotics-for-clinically-diagnosed-acute-sinusitis ... /) #Diagnosis ... #Algorithm
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... Obstructive Pulmonary ... corticosteroids, antibiotics ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... & Dry) is the treatment ... #algorithm #management ... #cardiology #treatment ... icu #clinical #pharmacology
Crohn's Disease & New Diagnosis of Colon Cancer Algorithm
 - Define Colonic Disease Extent, Activity &
Disease & New Diagnosis ... of Colon Cancer Algorithm ... Disease Extent, Activity ... ↑ rates intact fertility ... #management #treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... no evidence of active ... and molecular diagnostic ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... muscarinic agonists • Active